Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients
Authors:
- Marta ScorsettiMSMarta Scorsetti
- Antonella FogliataAFAntonella Fogliata
- Simona CastiglioniSCSimona Castiglioni
- Caterina BressiCBCaterina Bressi
- Mario BignardiMBMario Bignardi
- Piera NavarriaPNPiera Navarria
- Pietro MancosuPMPietro Mancosu
- Luca CozziLCLuca Cozzi
- Sara PentimalliSPSara Pentimalli
- Filippo AlongiFAFilippo Alongi
- Armando SantoroASArmando Santoro
Open Access
- 15 October 2010
- journal article
- Published by Springer Nature in Radiation Oncology
- Vol. 5 (1) , 93
Abstract
Background: To report about early clinical experience in radiation treatment of head and neck cancer of different sites and histology by volumetric modulated arcs with the RapidArc technology. Methods: During 2009, 45 patients were treated at Istituto Clinico Humanitas with RapidArc (28 males and 17 females, median age 65 years). Of these, 78% received concomitant chemotherapy. Thirty-six patients were treated as exclusive curative intent (group A), three as postoperative curative intent (group B) and six with sinonasal tumours (group C). Dose prescription was at Planning Target Volumes (PTV) with simultaneous integrated boost: 54.45Gy and 69.96Gy in 33 fractions (group A); 54.45Gy and 66Gy in 33 fractions (group B) and 55Gy in 25 fractions (group C). Results: Concerning planning optimization strategies and constraints, as per PTV coverage, for all groups, D98% > 95% and V95% > 99%. As regards organs at risk, all planning objectives were respected, and this was correlated with observed acute toxicity rates. Only 28% of patients experienced G3 mucositis, 14% G3 dermitis 44% had G2 dysphagia. Nobody required feeding tubes to be placed during treatment. Acute toxicity is also related to chemotherapy. Two patients interrupted the course of radiotherapy because of a quick worsening of general clinical condition. Conclusions: These preliminary results stated that volumetric modulated arc therapy in locally advanced head and neck cancers is feasible and effective, with acceptable toxicities.Keywords
This publication has 28 references indexed in Scilit:
- Volumetric modulated arc therapy: IMRT in a single gantry arcMedical Physics, 2007
- Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationshipRadiotherapy and Oncology, 2007
- Intensity-Modulated Radiotherapy of Head and Neck Cancer Aiming to Reduce Dysphagia: Early Dose–Effect Relationships for the Swallowing StructuresInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Intensity-Modulated Radiation Therapy for Head and Neck CarcinomaThe Oncologist, 2007
- The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- GLAaS: An absolute dose calibration algorithm for an amorphous silicon portal imager. Applications to IMRT verificationsMedical Physics, 2006
- Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Intensity‐modulated radiation therapy in head and neck cancers: An updateHead & Neck, 2005
- Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patientsRadiotherapy and Oncology, 2003
- Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999